Skip to main navigation Skip to search Skip to main content

Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

The rapid emergence of COVID-19 has sent shockwaves through healthcare systems globally, with cancer patients at increased risk. The interplay of the virus and host immune system has been implicated in the development of ARDS. Immunotherapy agents have the potential to adversely potentiate this phenomenon, requiring careful real-world observation.

Original languageEnglish
Pages (from-to)691-693
Number of pages3
JournalBritish Journal of Cancer
Volume123
Issue number5
DOIs
Publication statusPublished - Sept 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?'. Together they form a unique fingerprint.

Cite this